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Background and Purpose: Up to 50–60% of all cancer patients receive radiotherapy
as part of their treatment strategy. However, the mechanisms accounting for increased
vascular risks after irradiation are not completely understood. Mitochondrial dysfunction
has been identified as a potential cause of radiation-induced atherosclerosis.
Materials and Methods: Assays for apoptosis, cellular metabolism, mitochondrial
DNA content, functionality and morphology were used to compare the response of
endothelial cells to a single 2 Gy dose of X-rays under basal conditions or after
pharmacological treatments that either reduced (EtBr) or increased (rosiglitazone)
mitochondrial content.
Results: Exposure to ionizing radiation caused a persistent reduction in mitochondrial
content of endothelial cells. Pharmacological reduction of mitochondrial DNA content
rendered endothelial cells more vulnerable to radiation-induced apoptosis, whereas
rosiglitazone treatment increased oxidative metabolism and redox state and decreased
the levels of apoptosis after irradiation.
Conclusion: Pre-existing mitochondrial damage sensitizes endothelial cells to ionizing
radiation-induced mitochondrial dysfunction. Rosiglitazone protects endothelial cells
from the detrimental effects of radiation exposure on mitochondrial metabolism and
oxidative stress. Thus, our findings indicate that rosiglitazone may have potential value
as prophylactic for radiation-induced atherosclerosis.
Keywords: ionizing radiation, endothelial cells, rosiglitazone, mitochondria, cardiovascular disease
INTRODUCTION
High radiation doses (≥2 Gy) are known to increase the risk of cardiovascular diseases (CVD) after
radiotherapy (RT) (Hildebrandt, 2010; Shimizu et al., 2010; Darby et al., 2013). Given that 50 –
60% of all cancer patients receive RT in their treatment scheme (Gottfried et al., 1996), the excess
risk of developing CVD is a societal concern. Yet, the vascular effects of ionizing radiation are
not completely understood, as knowledge of the underlying biological and molecular mechanism
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of radiation-induced CVD is currently limited (Little et al.,
2008; Hildebrandt, 2010), resulting in possibly inadequate
radiation protection.
One of the targets of ionizing radiation that is linked
to radiation-induced CVD is the endothelium (Little et al.,
2008; Hildebrandt, 2010). Exposure of endothelial cells to
radiation results in endothelial cell dysfunction (Bhattacharya
and Asaithamby, 2016), promoting the development and
progression of atherosclerosis (Vita and Keaney, 2002; Widmer
and Lerman, 2014). Atherosclerosis is a complex process in which
arteries narrow due to plaque formation, a process characterized
by DNA damage, inflammation, senescence and apoptosis (Yu
et al., 2012). Recent evidence indicates that mitochondria play a
crucial role in the cellular and molecular mechanisms underlying
atherosclerosis. In most cells mitochondria supply the bulk
of cellular energy reserves through the process of oxidative
phosphorylation (OXPHOS). Endothelial cells, however, are
reported to be glycolytic and to minimally rely on mitochondria
for ATP generation. Rather than providing energy, mitochondria
in endothelial cells may act as signaling organelles that control
cytosolic Ca2+ signaling or modify reactive oxygen species
(ROS) (Wilson et al., 2019). While minute levels of ROS are
crucial for cellular signaling pathways, an excess can lead to a
state of oxidative stress, which may drive cells into senescence
or trigger apoptosis (Yu et al., 2012; Sieprath et al., 2015).
Likewise, dysregulation of cellular calcium homeostasis may
lead to cell death.
In humans, mitochondrial dysfunction has been evidenced
by the presence of mitochondrial DNA (mtDNA) damage in
the vessel wall, in atherosclerotic plaques and in circulating
leukocytes of patients affected by atherosclerosis (Corral-
Debrinski et al., 1992; Bogliolo et al., 1999; Botto et al., 2005).
Elevated human leukocytic mtDNA damage was also found to
be indicative of a higher atherosclerosis risk (Yu et al., 2013).
Experiments using ApoE−/− mice which harbor a polymerase
gamma mutation (that makes them more prone to accumulate
mtDNA mutations) revealed that elevated aortic mtDNA damage
was associated with an increased atherosclerotic plaque size, thus
providing direct causal evidence (Yu et al., 2013). Moreover,
a range of studies have demonstrated the presence of changes
in mitochondrial number, structure and function after exposure
of different types of cells and tissues to high (5–20 Gy) doses
of ionizing radiation, indicating induction of mitochondrial
dysfunction (Pandey et al., 2006; Nugent et al., 2007; Dayal
et al., 2009; Hu et al., 2017; Lafargue et al., 2017). However,
findings specifically focusing on the effect of ionizing radiation
exposure on endothelial mitochondria are scarce. Therefore,
we investigated (Darby et al., 2013) whether a single exposure
to a therapeutically relevant single radiation dose induces
mitochondrial dysfunction in endothelial cells, (Shimizu et al.,
2010) how mitochondrial dysfunction (such as pre-existing in
people with an increased atherosclerotic burden) can affect the
endothelial cell response to ionizing radiation, and (Hildebrandt,
2010) whether treatment of endothelial cells with rosiglitazone,
a peroxisome proliferator-activated receptor gamma (PPARγ)
agonist, could help sustain mitochondrial function after exposure
to ionizing radiation.
MATERIALS AND METHODS
Cells and Irradiation
Human telomerase-immortalized coronary artery endothelial
(TICAE) cells (from the European Collection of Authenticated
Cell Cultures [ECACC]) were grown in Human MesoEndo
Endothelial Cell Medium (Cell Applications catalog #212–500)
and cultured at 37◦C with 5% CO2 in a humidified incubator.
Cells were irradiated at confluence with 2 Gy X-rays (dose rate of
0.50 Gy/min), using an Xstrahl RX generator (250 kV, 12 mA,
3.8 mm Al and 1.4 mm Cu). Sham-irradiated cells were used
as control. Cells were not passaged after exposure. For lentiviral
production, HEK-293T/17 cells (from American Type Culture
Collection [ATCC]) were maintained in DMEM (Thermo Fisher
Scientific) supplemented with 1% L-glutamine (Sigma-Aldrich),
10% fetal bovine serum, 1% penicillin/streptomycin, 1% non-
essential amino acids, and 0.1% sodium pyruvate (Thermo
Fisher Scientific). In order to induce mitochondrial dysfunction
in endothelial cells, TICAE cells were grown in 50 ng/ml
ethidium bromide (Sigma-Aldrich) for 7 weeks to yield TICAE-
EtBr cells (King and Attardi, 1989). Other TICAE cells were
treated with 50 µM PPARγ agonist rosiglitazone (Sigma-Aldrich)
for their entire lifespan (TICAE-ROSI cells). Because mtDNA-
damaged cells are auxotrophic for uridine and pyruvate (King
and Attardi, 1989), TICAE-EtBr cells were kept in Human
MesoEndo Endothelial Cell Medium (Cell Applications catalog
#212–500) supplemented with 50 µg/ml uridine (Applichem),
2 mM L-glutamine, 100 µg/ml sodium pyruvate and 25 mM
HEPES. TICAE-ROSI cells were cultured in non-supplemented
Human MesoEndo Endothelial Cell Medium (Cell Applications
catalog #212–500).
Generation of Mito-GFP-Expressing
Endothelial Cells
Lentiviral particles were produced in HEK-293T/17 cells with
the LentiStarter 2.0 kit (System Biosciences) by transfecting
10 µg pCT-Mito-GFP-pCMV lentiviral construct (CYTO102-
PA-1) along with 2 µg transfer plasmid, 20 µl pPACKH1 plasmid
mix (Systems Biosciences) and 8 µg/ml polybrene (Sigma-
Aldrich) per 10 cm-wide dish. At 18 h post transfection, fresh
medium was added to cells. Virus-containing supernatants were
collected 24 and 48 h later. Samples were combined, centrifuged,
filtered through a 0.45-micron filter, aliquoted, and stored
at −80◦C. At 50% confluence, TICAE cells were transduced
in Human MesoEndo Endothelial Cell Medium containing
>5 × 105 infectious units/ml. After 72 h, stable expressing cells
were selected with 1 µg/ml puromycin.
Mitochondrial DNA Copy Number Assay
Total DNA was extracted using the QIAamp DNA mini kit
(Qiagen) with RNase treatment, according to the manufacturer’s
instructions. To quantify mtDNA copy number, TaqMan RT-
PCR was performed using a 7,500 Fast Real-Time PCR system
(Applied Biosystems). TaqMan Universal Master Mix II (Thermo
Fisher Scientific) was used according to the manufacturer’s
instructions, with 1x TaqMan RNase P copy number reference
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(Thermo Fisher Scientific) and a mtDNA specific primer-probe
combination that has been described elsewhere (forward primer:
GTA-CCC-ACG-TAA-AGA-CGT-TAG-G; reverse primer: TAC-
TGC-TAA-ATC-CAC-CTT-CG) (Pogozelski et al., 2003). The
mtDNA content was defined as the ratio of mtDNA specific
sequence to the single-copy human nuclear control gene RNase
P (Thermo Fisher Scientific).
Mitochondrial Content Measurement
Cells were plated at 10,000 cells/well in 96-well plates. After
irradiation, cells were imaged at 10 × magnification in an
IncuCyte Zoom Live-content imaging system (Essen Bioscience)
at 37◦C, 5% CO2. Images (2/well) were recorded every 2 h
for 5 days. Data were analyzed using IncuCyte analysis
software to detect and quantify mtGFP-expressing mitochondrial
content/image. Results were normalized according to the degree
of confluence as determined with phase contrast images.
High Content Live Cell Imaging of
Intracellular ROS and Mitochondrial
Membrane Potential
Levels of intracellular ROS and mitochondrial membrane
potential were measured as described elsewhere (Sieprath
et al., 2016; Sieprath et al., 2017). Briefly, (sham-)irradiated
endothelial cells were grown in 96-well plates and stained for
25 min at room temperature with 2 µM chloromethyl-2′,7′-
dichlorodihydrofluorescein diacetate (CM-H2DCFDA) (Life
Technologies) together with 100 nM tetramethyl rhodamine
methyl ester (TMRM, Invitrogen). After washing in Hank’s
balanced salt solution with 20 mM HEPES, all wells (4 fields
per well) were imaged sequentially with a Nikon Ti Eclipse
inverted wide field fluorescence microscope using a 20x air
Plan Fluor objective (NA 0.50). After this first imaging cycle,
20 µM tert-butyl peroxide (tBHP, Sigma-Aldrich) was added
and after 3 min the same acquisition cycle was repeated All
images were processed with an automated image analysis script
(RedoxMetrics.ijm) for FIJI (National Institutes of Health1, 1997–
2014). This pipeline is based on a sequence of image processing
steps including a flat field correction, noise reduction by Gaussian
filtering, cell or mitochondrial segmentation and subsequent
feature analysis of regions of interest. For CM-H2DCFDA,
cell segmentation was performed by automatic thresholding
according to Huang’s algorithm (Huang, 1989) and average
intensities were measured within the segmented regions. For
TMRM, mitochondrial signals were enhanced by local contrast
enhancement and multi-scale Laplacian filtering, after which
binarization was performed using Huang’s algorithm. Resulting
masks were used to measure signal intensities of objects larger
than three pixels on the original image.
ATP Assay
Intracellular ATP levels were measured using the ATPlite 1step
assay (Perkin Elmer) according to manufacturer’s instructions.
Briefly, cells in a 96-well plate were lysed with ATPlite solution
1http://rsb.info.nih.gov/ij/
at different times after irradiation. After shaking (700 RPM,
2 min), luminescence signals were measured with a CLARIOstar
microplate reader (BMG LABTECH).
Oximetry
OCR levels were measured using a Cell Mito Stress Test
Kit on a Seahorse XF96 analyzer (Agilent) according to
manufacturer’s instructions. Briefly, cells were irradiated and
plated at 20,000 cells/well in XF96-well plates. The next day,
cells were washed and equilibrated with buffer-free medium
(DMEM + Glutamax with 10 mM glucose and 2 mM
L-glutamine) at 37◦C in a CO2-free incubator for 1 h. Initial
measurements of ECAR and OCR were collected. Cells were
then consecutively treated with 1 µM oligomycin, 1 µM
FCCP and 0.5 µM rotenone/antimycin A, during which OCR
values were assessed. Data were normalized to cell numbers
obtained by counting cell nuclei after paraformaldehyde fixation
and DAPI staining.
Apoptosis Assays
For caspase 3/7 activation and annexin V apoptosis assays, cells
were plated at 6,000 cells/well in 96-well plates. Caspase 3/7
and annexin V green reagent (Essen Bioscience) was added at a
1:1,500 dilution. Cells were imaged at 10 × magnification on an
IncuCyte Zoom Live-content imaging system (Essen Bioscience)
at 37◦C, 5% CO2. Two images/well were acquired every 2 h for
98 h. Data were analyzed using the IncuCyte analysis software.
Results were normalized to total cell count determined with
NucLight (Essen Bioscience), a nuclear label for living cells. The
apoptotic index was calculated by dividing the final apoptotic cell
count by the total cell count per irradiation group (either 0 or
2 Gy) and then dividing the respective values of 2 Gy by those
of the 0 Gy group.
Transmission Electron Microscope (TEM)
Imaging
Cells were seeded on Thermanox slides (Nunc). After irradiation,
cells were fixed with 2% glutaraldehyde in 0.05 M cacodylate
buffer (pH 7.3) at 4◦C. The fixative was removed, and samples
were post-fixed in 2% osmium tetroxide for 1 h at room
temperature, followed by staining with 2% uranyl-acetate in
10% acetone for 20 min at room temperature. Samples were
gradually dehydrated by a series of graded acetone concentrations
and embedded in epoxy resin (Araldite). Ultra-thin sections
(0.06 µm thick) were mounted on 0.7% formvar coated grids
(Agar scientific), contrasted with uranyl-acetate followed by lead
citrate, and examined on a Philips EM 208 transmission electron
microscope operating at 80 kV.
Statistics
Data show means ± SEM. Data were analyzed using GraphPad
v7.0.2. Data from mtGFP, mitochondrial OXPHOS, ATP,
oxidative stress and TMRM measurements were analyzed by two-
way ANOVA with Bonferroni post hoc test. Data from cellular
mtDNA content and cell death measurements were analyzed
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by one-way ANOVA with Tukey post hoc test. P < 0.05 was
considered to be statistically significant.
RESULTS
Irradiated Endothelial Cells Have a
Persistently Low Mitochondrial Number
To gain more knowledge about the mitochondrial effects of X-ray
irradiation on endothelial cells, we first tested whether irradiation
of TICAE cells (Figure 1A) constitutively expressing mtGFP (a
marker of mitochondrial content) with a single 2 Gy X-ray dose
induced changes in mitochondrial number during a time span
of 98 h after ionizing radiation exposure. We found that the
mGFP signal, normalized according to the degree of confluence
as determined with phase contrast images, increased at a slower
rate in 2 Gy-irradiated compared to sham-irradiated TICAE
cells over time, with “time after irradiation,” “radiation dose”
and their interaction being significantly different (P < 0.0001;
Figures 1A,B).
More Abundant Mitochondria Decrease
Apoptosis in Irradiated Endothelial Cells
To study how preexisting mitochondrial dysfunction can affect
TICAE cell response to ionizing radiation exposure, cells were
treated either chronically with ethidium bromide to generate
FIGURE 1 | Irradiation decreases TICAE cell mitochondrial abundance. (A) The graph shows mitochondrial GFP content per cell over time in sham-irradiated and
2 Gy-irradiated TICAE cells, determined using live cell imaging and normalized according to masked cell count based on bright field images. P-values are indicated
as colored blocks (N = 3, n = 12). (B) Representative images of 0 Gy 48 h after irradiation (left) and a 2 Gy 48 h after irradiation (right). Bar = 300 µm. Statistics were
performed by a multiple comparison two-way ANOVA with Bonferroni post hoc test.
Frontiers in Pharmacology | www.frontiersin.org 4 March 2020 | Volume 11 | Article 268
fphar-11-00268 March 11, 2020 Time: 18:51 # 5
Baselet et al. Rosiglitazone Protects Irradiated Endothelial Mitochondria
FIGURE 2 | Validation of TICAE-EtBr and TICAE-ROSI models. mtDNA copy
number in untreated TICAE cells (control) and in TICAE-EtBr and TICAE-ROSI
cells (N = 3, n = 12). *P < 0.05 and ***P < 0.001 by one-way ANOVA with
Tukey post hoc test.
TICAE-EtBr cells with mitochondrial dysfunction (King and
Attardi, 1989) or with rosiglitazone to increase mitochondrial
function in TICAE-ROSI cells (Wilson-Fritch et al., 2003).
mtDNA copy number was assessed relative to nuclear DNA.
Untreated TICAE cells had an average of 235.02± 35.00 mtDNA
copies per cell (Figure 2). In comparison, TICAE-EtBr cells
had a significantly diminished amount of mtDNA copies per
cell (0.71 ± 0.17) and TICAE-ROSI cells a significantly elevated
amount of mtDNA copies per cell (718.30± 111.68).
We then compared the response of the cells to irradiation.
Following a 2 Gy X-ray dose, a high amount of apoptotic
TICAE cells was observed (Figure 3). TICAE-EtBr responded
with the same amplitude. Comparatively, TICAE-ROSI cells had
significantly lower apoptotic indexes based on either annexin V
content (20.42 ± 1.59) or caspase 3/7 activity (18,83 ± 0.55)
than TICAE cells (26.20 ± 0.97 for annexin V and 29.11 ± 0.83
for caspase 3/7 activity) and TICAE-EtBr cells, (respectively,
26.07± 0.94 and 29.61± 1.38).
Irradiation Decreases Endothelial Cell
Respiration but Increases Their
Oxidative Capacity
mtDNA is not protected by histones and could be a primary target
of ionizing radiation in endothelial cells. Using oximetry, we
therefore tested whether irradiation could impact mitochondrial
respiration in our cell models. As expected, basal respiration,
respiration used for ATP production, maximal respiration and
spare respiratory capacity were all lower in sham-irradiated
TICAE-EtBr and all higher in TICAE-ROSI compared to TICAE
cells (Figure 4). In TICAE cells, a single 2 Gy X-ray exposure
significantly decreased basal respiration and respiration used for
ATP production, whereas it increased maximal respiration and
the spare capacity measured 24 h later. Compared to sham,
irradiated TICAE-EtBr had unchanged basal respiration and
respiration used for ATP production, but maximal respiration
and spare capacity slightly increased, although with a much lower
amplitude compared to TICAE cells, indicating that TICAE-EtBr
were not totally devoid of mitochondria. Irradiated TICAE-
ROSI cells responded to irradiation in the same way as TICAE
cells, but changes were of a larger amplitude. Thus, irradiation
decreased actual respiration rates of the cells but increased their
potential to respire.
Irradiation Minimally Affects the
Intracellular ATP Content of Endothelial
Cells
Endothelial cells produce most of their ATP through glycolysis
(De Bock et al., 2013). Still, the decreased oxygen consumption
rates that we observed after irradiation could potentially impact
intracellular ATP levels. We therefore analyzed ATP content over
time. In sham-irradiated conditions, TICAE and TICAE-ROSI
cells had stable ATP levels, which were significantly higher in
FIGURE 3 | Rosiglitazone treatment protects TICAE cells against irradiation. Graphs show the apoptotic index of TICAE, TICAE-EtBr and TICAE-ROSI cells 98 h
after a single 2 Gy irradiation, using annexin V (left) and activated caspase 3/7 staining (right) (N = 2, n = 7–14). *P < 0.05, **P < 0.01, ****P < 0.0001 by one-way
ANOVA with Tukey post hoc test.
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FIGURE 4 | Irradiation decreases TICAE cell respiration but increases their respiration capacity. The rates of basal respiration, respiration linked to ATP production,
maximal respiration and spare respiratory capacity were measured using Seahorse oximetry in TICAE, TICAE-EtBr and TICAE-ROSI cells 24 h after sham ( ) or 2 Gy
X-ray () exposure (N = 3, n = 32–64). *P < 0.05, ****P < 0.0001 by two-way ANOVA with Bonferroni post hoc test.
TICAE-ROSI (Figure 5). TICAE-EtBr had lower ATP levels,
which nevertheless progressively increased over time, probably
reflecting a higher glycolytic activity, as previously shown in
cancer cells (Sonveaux et al., 2008). Irradiation minimally
but statistically significantly impacted ATP levels in all 3 cell
lines with “time after irradiation,” “radiation dose” and their
interaction being significantly different (all P < 0.0001; except
“radiation dose” TICAE-ROSI: P < 0.05).
Mitochondria Control Redox Stress in
Endothelial Cells After Irradiation
Dysfunctional mitochondria are well known to have altered
mtROS production (Gutterman, 2005; Kumari et al., 2014).
In endothelial cells, intracellular ROS levels were similar
in sham-irradiated TICAE, TICAE-EtBr, and TICAE-ROSI
cells (Figure 6A). A single 2 Gy X-ray irradiation increased
intercellular ROS content 24 h after irradiation only in TICAE-
ROSI cells, which also displayed the highest oxidative capacity
(see Figure 4).
We also tested resistance to redox stress by measuring
intracellular ROS levels after challenging the cells with tBHP.
TICAE-EtBr and TICAE-ROSI cells were more efficient to
inactivate exogenously delivered ROS compared to TICAE
(Figure 6B). However, the opposite was observed when
performing tBHP treatment 24 h after irradiation, indicating
that TICAE-EtBr and TICAE-ROSI exhaust their antioxidant
defense systems faster than TICAE cells. Accordingly, TICAE-
EtBr and TICAE-ROSI had a higher mitochondrial potential
compared to TICAE cells, both in sham and irradiated
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FIGURE 5 | Irradiation minimally affects ATP levels in endothelial cells.
Measurements of ATP concentrations in TICAE, TICAE-EtBr and TICAE-ROSI
cells at increasing times after a sham or a 2 Gy X-ray irradiation (N = 2,
n = 24). ****P < 0.0001 using two-way ANOVA with Bonferroni post hoc test.
conditions, (Figure 6C), which is generally associated with a high
mitochondria-generated redox stress (Korshunov et al., 1997;
Turrens, 2003).
Irradiation Triggers Mitochondrial
Remodeling in Endothelial Cells
To associate mitochondrial dysfunction to potential alteration
of mitochondrial morphology, we first examined mitochondrial
area and circularity after TMRM staining. Compared to TICAE,
TICAE-EtBr cells had an increased mitochondrial area per
cell with qualitatively less circular mitochondria in the sham
condition, but an increased mitochondrial area with normal
circularity 24 h after 2 Gy X-ray-irradiation (Figures 7A,B).
TICAE and TICAE-ROSI cells had similar mitochondrial areas
per cell in the sham condition, but it increased in irradiated
TICAE-ROSI cells. Mitochondrial circularity was statistically
different between the cell types and treatment conditions, of
which high mitochondrial circularity is associated with a high
redox stress state (Ahmad et al., 2013; Hung et al., 2018).
Ultrastructural characterization was performed on TEM
images (Figure 7C). Sham-irradiated TICAE cells showed
a regular aligned plasma membrane and a nucleus with
normally distributed heterochromatin. Mitochondria were
distributed throughout the cytoplasm with well-organized
cristae. Comparatively, sham-irradiated TICAE-EtBr cells
showed spreading and blebbing of the plasma membrane.
Their mitochondria were swollen and showed disruption of the
cristae. TICAE-ROSI cells were represented by cells with either
a regular aligned plasma membrane and or with shedding of
small cytoplasmic vesicles. The majority of the mitochondria
had a small size, elongated phenotype, and a minority showed
disrupted cristae. Twenty-four hours after irradiation, TICAE
and TICAE-EtBr cells were characterized by plasma membrane
spreading and blebbing and swollen mitochondria with disrupted
cristae. TICAE-ROSI cells responded differently, displaying a
normal, aligned plasma membrane with small elongated
mitochondria and a dense matrix.
DISCUSSION
Our study aimed at investigating (Darby et al., 2013) whether
irradiation with a therapeutically relevant dose of X-rays
induces mitochondrial dysfunction in endothelial cells,
(Shimizu et al., 2010) how endothelial cells with preexisting
mitochondrial dysfunctions respond to ionizing radiation
exposure, and (Hildebrandt, 2010) whether rosiglitazone can
prevent irradiation-induced mitochondrial dysfunctions in
endothelial cells.
In respect to the first aim, we report that TICAE cell
irradiation promotes apoptosis and induces mitochondrial
dysfunction as shown by reduction in basal respiration and
lowered ATP synthesis. However, OXPHOS capacity was
intact, as substantiated by increased maximal respiration and
spare respiratory capacity. In the same line, a recent study
in fibroblasts showed a correlation between decreased basal
respiration and apoptosis with normal maximal respiration
FIGURE 6 | Endothelial cells with dysfunctional mitochondria have difficulties to cope with redox stress upon irradiation. (A) Intracellular ROS measurements in
TICAE, TICAE-EtBr and TICAE-ROSI cells 24 h after a sham or a 2 Gy X-ray irradiation (N = 3, n = 32). (B) Same as A but basal ROS were measured after exposing
the cells to 20 µM tert-butyl peroxide (tBHP) (N = 3, n = 32). (C) Mitochondrial membrane potential of TICAE, TICAE-EtBr and TICAE-ROSI cells 24 h after a sham or
a 2 Gy X-ray irradiation (N = 3, n = 32). ***P < 0.005, ****P < 0.0001 by two-way ANOVA with Bonferroni post hoc test.
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FIGURE 7 | Irradiation alters mitochondrial morphology in endothelial cells. (A) Mitochondrial surface relative to cell surface was measured in TMRM-stained TICAE,
TICAE-EtBr and TICAE-ROSI cells 24 h after a sham or a 2 Gy X-ray irradiation (N = 3, n = 32). (B) As in A, but measuring mitochondrial circularity (N = 3, n = 32).
(C) Representative TEM pictures of TICAE, TICAE-EtBr and TICAE-ROSI cells 24 h after a sham or a 2 Gy X-ray irradiation. Black arrows point at normal
mitochondria and white arrows at abnormal mitochondria. Bars = 5 µm. *P < 0.05, ****P < 0.0001 by two-way ANOVA with Bonferroni post hoc test.
(Kandel et al., 2016; Jang et al., 2017). The authors coupled
the reduction in basal respiration to a disarrangement of
the cytoskeleton that inhibited mitochondrial attachment.
Similarly, ultrastructural analysis of TICAE cells after irradiation
showed a disorganization of the cellular architecture with
the presence of mitochondrial swelling and cristae disruption.
Hu et al. (2017) previously demonstrated that a 5–20 Gy
γ-ray-irradiation of human umbilical vein endothelial cells
(HUVEC) induced apoptosis together with increased ROS
production and decreased mitochondrial membrane potential
24 h after exposure. In contrast, our study reveals no changes
in mitochondrial membrane potential, ROS levels and redox
defenses. This could be due to the lower ionizing radiation
dose of 2 Gy that we used, as ROS production in the work
of Hu et al. (2017) was found to be dose-dependent. From
a pathophysiological standpoint, mitochondrial dysfunction
can induce atherosclerosis, as mentioned in the introduction.
Thus, the mitochondrial dysfunction that we observed in
irradiated TICAE cells could potentially activate molecular
pathways underlying radiation-induced atherosclerosis observed
in exposed individuals (Shimizu et al., 2010; Darby et al., 2013),
which warrants further investigation.
Our second aim was to determine whether a preexisting
mitochondrial dysfunction could alter the response of endothelial
cells to ionizing radiation. To address this question, we
generated TICAE-EtBr and TICAE-ROSI cells. As expected,
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compared to TICAE, non-irradiated TICAE-EtBr cells had
decreased basal and maximal respiratory rates, diminished ATP
production and an abnormal mitochondrial morphology. They
had improved redox stress resistance in basal conditions. Upon
irradiation, TICAE-EtBr cells showed a further deterioration
characterized by the inability to detoxify intracellular ROS in
the presence of an exogenous peroxide and affected (albeit
minimally) ATP production kinetics. Reduced redox resistance
could be explained by the advanced disintegration of the
mitochondrial network after irradiation, of which important
characteristics are mitochondrial swelling (that we evidenced
using TEM and fluorescent microscopy), a reduction of the
number of mitochondria, a decrease in mitochondrial area
and diminished mitochondrial membrane potential. From these
data, we conclude that irradiation worsens mitochondrial
function in our TICAE-EtBr endothelial cells with a preexisting
mitochondrial dysfunction. Based on our results, we propose
that the mitochondrial dysfunction that is already present
in established atherosclerotic plaques (Bogliolo et al., 1999)
could be aggravated by ionizing radiation exposure in clinical
settings. If this hypothesis was true, then irradiation could
accelerate and worsen atherosclerosis outcome, which deserves
experimental evaluation.
Our third aim was to determine whether endothelial cells
could be protected against irradiation-induced mitochondrial
dysfunction. To address this point, we chronically treated TICAE
cells with rosiglitazone. This compound is a member of the
thiazolidinedione family that activates peroxisome proliferator-
activated receptor γ coactivator- α1 (PGC-1α), promoting
mitochondrial biogenesis in adipose tissue (Wilson-Fritch et al.,
2003) and HUVECs (Fujisawa et al., 2009). Other studies
confirmed that activation of PGC-1α by rosiglitazone stimulates
mitochondrial biogenesis and OXPHOS (Pardo et al., 2011;
Zhang et al., 2018). In addition, rosiglitazone has radioprotective
properties, as it is able to protect 12 Gy-irradiated mice from
intestinal toxicity by reversing the inflammatory and apoptotic
changes induced by radiation (Mangoni et al., 2017). Compared
to TICAE, non-irradiated TICAE-ROSI cells had improved
mitochondrial function, as evidenced by an elevated basal
and maximal respiratory capacity, increased spare respiratory
capacity and a marked increase in ATP production. The higher
respiratory capacity of TICAE-ROSI cells was associated with
the presence of elongated mitochondria, suggesting a process of
mitochondrial adaptive remodeling. When delivering exogenous
ROS, intracellular ROS levels were even decreased compared
to TICAE cells, suggesting an intact ROS scavenging system.
These data are in line with a previous study (Karnewar et al.,
2016) in which treatment of human aortic endothelial cells
with mitochondria-targeted esculetin, a member of the coumarin
family with anti-inflammatory and anti-oxidant properties,
resulted in a similar increase in respiratory capacity and
resistance to oxidative stress. Other studies confirmed the
upregulation of PGC-1α expression by ROSI, as it has been
shown to promote mitochondrial biogenesis and to maintain
OXPHOS (Pardo et al., 2011; Zhang et al., 2018). Upon
irradiation, compared to TICAE, TICAE-ROSI cells showed an
increased respiration capacity, enhanced respiration used for
ATP production and decreased apoptosis. However, TICAE-
ROSI behaved as TICAE-EtBr cells when exposed to oxidative
stress, thus undergoing faster exhaustion of redox defenses
than TICAE cells. Despite limited redox defenses, mitochondrial
dysfunction and apoptosis were limited after irradiation. This
might be due to an adaptive response protecting TICAE-
ROSI cells against an overflow of ROS, as was observed in
other cells (Belikova et al., 2009) and animals (Bakkal et al.,
2013). Therefore, we conclude that rosiglitazone improved
mitochondrial function in our model and protects against
irradiation-induced apoptosis.
CONCLUSION
We report that a single 2 Gy X-ray dose induces mitochondrial
dysfunction in endothelial cells. Furthermore, TICAE-EtBr cells
demonstrated a diminished mitochondrial function and a higher
oxidative stress state after radiation exposure. TICAE-ROSI
cells revealed enhanced mitochondrial function, resulting in a
higher oxidative stress state, but an overall decrease in apoptosis
after irradiation potentially due to preconditioning. Future
research should look into therapeutically relevant fractionated
radiation schemes to fully grasp the scope of the role of
endothelial mitochondria in radiation-induced cardiovascular
diseases. Other open questions that need to be resolved are
the effect of ionizing radiation on mtDNA, mitochondrial
fission, fusion, redox balance, mitophagy and the interplay
with rosiglitazone treatment and PGC-1α in endothelial cells.
As a result, improved understanding of radiation-induced
cardiovascular diseases would prove valuable for the protection
of patients exposed to ionizing radiation.
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